Skip to main content

Treatment of Resistant Hodgkin’s Lymphoma with Bone Marrow Transplantation in Italy

  • Conference paper
Book cover New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 117))

Abstract

High-dose chemotherapy and autologous or allogeneic bone marrow transplantation are known to be useful in patients with hematological malignancies. The encouraging results of this approach in the treatment of acute leukemias prompted us to investigate its use in patients with Hodgkin’s lymphoma not being cured by primary conventional chemotherapy.

This work was supported by the Associazione Italiana Ricera sul Cancro (A.I.R.C., 1989).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Carella AM, Congiu A, Santini G et al. (1986) High dose chemotherapy (HDC) and autologous bone marrow transplantation in advanced highly treated Hodgkin’s disease (AHTHD). Bone Marrow Transplant 1: 293–296

    Google Scholar 

  • Carella AM, Congiu A, Santini G et al. (1987) High-dose cyclophosphamide, etoposide and BCNU with autologous BMT (ABMT) rescue in advanced resistant Hodgkin’s disease patients. Bone Marrow Transplant 2 [Suppl 1]: 210

    Google Scholar 

  • Carella AM, Congiu A, Mazza P et al. (1988) High-dose chemotherapy with autologous BMT “rescue” in 50 advanced resistant Hodgkin’s disease patients. An Italian Study Group Report. J Clin Oncol 6 [Suppl 9]: 1411–1416

    PubMed  CAS  Google Scholar 

  • Jagannath S, Dicke KA, Armitage JO, Cabanillas F, Horwitz U, Vellekoop L, Zander AR, Spitzer G (1986) High dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapsed Hodgkin’s disease. Ann Intern Med 102: 163–168

    Google Scholar 

  • Santoro A, Bonfante V, Bonadonna G et al. (1982) Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin’s disease. Ann Intern Med 96: 139–143

    PubMed  CAS  Google Scholar 

  • Santoro A, Viviani S, Valagussa P et al. (1986) CCNU, etoposide and prednimustine (CEP) in refractory Hodgkin’s disease. Semin Oncol 13 [Suppl 1]: 23–26

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Carella, A.M., Marmont, A.M. (1989). Treatment of Resistant Hodgkin’s Lymphoma with Bone Marrow Transplantation in Italy. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83781-4_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83783-8

  • Online ISBN: 978-3-642-83781-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics